Trial Profile

A randomised, controlled Phase 1/2 study in healthy adults of a seasonal influenza vaccine containing an insulin-based adjuvant to evaluate safety and immunogenicity

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 22 Jun 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adjuvanted-influenza-virus-vaccine-inactivated-trivalent-Vaxine (Primary) ; ADVAX (Primary)
Indications Influenza virus infections
Focus Adverse reactions; First in man; Pharmacodynamics
Sponsors Vaxine

Most Recent Events

12 Jun 2016 Results of phase I part of this study (n=98) published in the Vaccine
29 Aug 2011 Status changed from active, no longer recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
11 May 2009 Status changed from not stated to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com